Skip to content
Canine PeptideResearch peptides

Is MGF safe for dogs?

The short answer

MGF is among the least-studied compounds on this site in any species, and there is no canine clinical data at all — the evidence is mechanistic. Its very short half-life means systemic exposure is limited, which is reassuring, but it shares the IGF-1 family contraindication: it should not be used in a dog with known or suspected cancer, and it should not be stacked with IGF-1 LR3.

The critical risks

Contraindicated with active cancer

As an IGF-1 family growth factor, MGF promotes cell proliferation. It should not be used in a dog with known or suspected malignancy.

Additional cautions

Do not stack with IGF-1 LR3

Both act on IGF-1 receptor pathways. Running them together stacks the same signal without added benefit and complicates attributing any adverse effect.

What the evidence base actually is

Safety claims are only as good as the studies behind them.

Preliminary / in vitro only1 cited study

MGF is a splice variant of the IGF-1 gene that muscle produces in response to mechanical loading and damage. Its half-life is extremely short — around fifteen minutes — which means it acts where it is placed. That is why protocols call for injecting close to the injured muscle rather than anywhere convenient.

Dosing context

Safety is dose-dependent. These are the figures reported in the source literature.

Weight classReported doseFrequencyDurationStudied for
Small / toy breedunder 22 lb (10 kg)20-50 mcg per dayDaily or every other day4-6 weeksLocalised muscle repair, post-injury recovery
Medium breed22–77 lb (10–35 kg)40-175 mcg per dayDaily or every other day4-6 weeksMuscle repair, post-injury recovery
Large / giant breedover 77 lb (35 kg)80-350 mcg per dayDaily or every other day4-6 weeksMuscle repair, muscle loss, post-injury recovery

See the full MGF profile for mechanism, protocol and monitoring detail.

Common questions

Is MGF safe for dogs?+

MGF is among the least-studied compounds on this site in any species, and there is no canine clinical data at all — the evidence is mechanistic. Its very short half-life means systemic exposure is limited, which is reassuring, but it shares the IGF-1 family contraindication: it should not be used in a dog with known or suspected cancer, and it should not be stacked with IGF-1 LR3.

What are the side effects of MGF in dogs?+

Contraindicated with active cancer: As an IGF-1 family growth factor, MGF promotes cell proliferation. It should not be used in a dog with known or suspected malignancy. Do not stack with IGF-1 LR3: Both act on IGF-1 receptor pathways. Running them together stacks the same signal without added benefit and complicates attributing any adverse effect.

Can MGF be given to a dog with cancer?+

No. MGF is contraindicated in dogs with active or suspected cancer. As an IGF-1 family growth factor, MGF promotes cell proliferation. It should not be used in a dog with known or suspected malignancy.

Does my dog need testing before starting MGF?+

No compound-specific genetic testing is established for MGF. Baseline bloodwork before starting, and repeat testing during a protocol, is standard practice and lets your veterinarian catch a problem before it becomes clinically apparent.

References

  1. 1.Goldspink G Mechanical signals, IGF-I gene splicing, and muscle adaptation. Physiology, 2005. PMID 16174871

Educational information — not veterinary medical advice

Everything on this page is compiled from published peer-reviewed literature for educational and research purposes. It does not establish a veterinarian-client-patient relationship (VCPR) and is not a substitute for veterinary examination and diagnosis. Most compounds described here are investigational or used off-label and are not FDA-approved for these purposes in dogs. Extralabel drug use in animals requires a valid VCPR and the direct supervision of a licensed veterinarian under AMDUCA (21 U.S.C. §360b). Dosing figures are reported as they appear in the source literature and are not recommendations.